A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis
Clinical trial NCT04562870 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04562870
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2026-09-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.